NAYA Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
NAYA Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • NAYA Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $2.34M, a 31.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.34M -$1.08M -31.5% Sep 30, 2024 10-Q 2024-11-19
Q2 2024 $2.34M +$80.1K +3.55% Jun 30, 2024 10-Q/A 2024-11-19
Q1 2024 $2.39M +$642K +36.7% Mar 31, 2024 10-Q/A 2024-11-19
Q4 2023 $3.36M +$1.94M +138% Dec 31, 2023 10-Q 2024-11-19
Q3 2023 $3.42M +$1.97M +136% Sep 30, 2023 10-K/A 2024-11-19
Q2 2023 $2.26M +$767K +51.4% Jun 30, 2023 10-K/A 2024-11-19
Q1 2023 $1.75M +$222K +14.5% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $1.41M -$151K -9.62% Dec 31, 2022 10-K/A 2024-11-19
Q3 2022 $1.45M +$440K +43.4% Sep 30, 2022 10-K/A 2024-11-19
Q2 2022 $1.49M +$462K +44.9% Jun 30, 2022 10-K/A 2024-11-19
Q1 2022 $1.53M +$1.45M +1975% Mar 31, 2022 10-K/A 2024-11-19
Q4 2021 $1.56M +$1.49M +1873% Dec 31, 2021 10-K/A 2024-11-19
Q3 2021 $1.01M +$928K +1092% Sep 30, 2021 10-K/A 2024-11-19
Q2 2021 $1.03M +$938K +1033% Jun 30, 2021 10-K/A 2024-11-19
Q1 2021 $73.6K -$22.7K -23.6% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $79.3K -$22.6K -22.1% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $85K -$22.4K -20.9% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $90.8K -$22K -19.5% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $96.4K Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $102K +$102K Dec 31, 2019 10-K 2021-03-30
Q3 2019 $107K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $113K Jun 30, 2019 10-Q 2019-08-14
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.